drugset / Trial / NCT03988283
Neoepitope-based Personalized DNA Vaccine Approach in Pediatric Patients With Recurrent Central Nervous System Tumors
Phase 1
Recruiting
7 enrolled
Washington University School of Medicine
Children's Discovery Institute · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this research study is to learn about the safety and feasibility of giving a personalized DNA vaccine to people with central nervous system tumors that have returned or have been resistant to treatment.
Timeline
- Start
- 2024-10-02
- Primary completion
- 2029-03-31
- Completion
- 2031-02-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Personalized neoantigen DNA vaccine | Vaccine | — | Intramuscular |